Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

22 58 59 65 23 13 36 34 49 63 101 62 44 26

Research, Review articles and Editorials

2 4 1 2 12 12 29 28 44 56 80 48 12 19

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 54 58 63 11 1 7 6 5 7 21 14 32 6

Conference proceedings

0 40 12 37 0 0 145 138 95 63 154 72 54 0

Citations received as per Google Scholar, other indexing platforms and portals

522 678 761 838 697 626 613 599 538 478 262 142 31 69
Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Daofang Ding, Leqin Xu, Hao Xu, Xiaofeng Li, Qianqian Liang, et al. (2014) Mash1 efficient reprograms rat astrocytes into neurons 9: 25-32

Ding D, Xu L, Xu H, Li X, Liang Q, et al. (2014) Mash1 efficiently reprograms rat astrocytes into neurons. Neural regeneration research 9: 25.

Edmonds RE, Garvican ER, Smith RK, Dudhia J (2016) Influence of commonly used pharmaceutical agents on equine bone marrow‐derived mesenchymal stem cell viability. Equine veterinary journal.

Broeckx SY, Borena BM, Van Hecke L, Chiers K, Maes S, et al. (2015) Comparison of autologous versus allogeneic epithelial-like stem cell treatment in an in vivo equine skin wound model. Cytotherapy 17: 1434-1446.

Broeckx S, M Borena B, Zimmerman M, Mariën T, Seys B, et al. (2014) Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients. Current stem cell research & therapy 9: 452-457.

Broeckx S, Suls M, Beerts C, Vandenberghe A, Seys B, et al. (2014) Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study. Current stem cell research & therapy 9: 497-503.

Broeckx S, Zimmerman M, Crocetti S, Suls M, Marien T, et al. (2014) Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoS One 9: e85917.

Ribeiro A (2016) Mesenchymal stromal cells: their immunosuppressive capacity and protein production profile (Doctoral dissertation).

Tiwari A, Wong CS, Nekkanti LP, Deane JA, McDonald C, et al. (2016) Impact of Oxygen Levels on Human Hematopoietic Stem and Progenitor Cell Expansion. Stem cells and development 25: 1604-1613.

Ribeiro A, Gill S, Satyam A, Joshi L, Zeugolis D, Ceredig R. Effects of hypoxia on the Extracellular Matrix produced by the mouse MS-5 Mesenchymal Stromal cell line.

Tiwari A, Moeneclaey G, Jenkin G, Kirkland MA (2016) Exploring life saving potential of umbilical cord blood derived hematopoietic stem cells. Insights in Stem Cells.

Tiwari A, Tursky ML, Nekkanti LP, Jenkin G, Kirkland MA, et al. (2014) Expansion of human hematopoietic stem/progenitor cells on decellularized matrix scaffolds. Current protocols in stem cell biology.

Darwish NH, Mousa SA (2016) Take a look at the Recent articles.

Darwish NH, Mousa SA (2016) Intrinsic targeting strategies against acute myeloid leukemic stem cells.

Al-Mawali A, Gillis D, Lewis I (2016) Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones. Journal of Hematology & Oncology 9: 61.

Ali F, Taresh S, Al-Nuzaily M, Mok PL, Ismail A, et al. (2016) Stem cells differentiation and probing their therapeutic applications in hematological disorders: a critical review. European review for medical and pharmacological sciences 20: 4390-4400.

HUHc YH, SHERLEY JL (2016) KRISHNANCHALI PANCHALINGAM, a MINSOO NOH, b. Human Stem Cell Toxicology: Issues in Toxicology 29: 250.

Thakur C (2016) Research & Reviews: Journal of Medical and Health Sciences.

Hu M, Yang Y, Ji Z, Luo J (2016) RBM15 Functions in Blood Diseases. Current cancer drug targets 16: 579-585.

Cromvik J (2015) Graft-versus-Host Disease: Eosinophils, Chimerism and Clinical Features in Patients Undergoing Allogeneic Hematopoietic Stem Cell or Multivisceral Transplantation.